GenoTwin
Precision medicine starts with complete pathogen insights.
New York, United States · Founded 2020 · $200K raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- genotwin.com
- Total Funding
- $200K
- Last Round
- $200K SeedDec 2020
- Rounds
- 1
About
GenoTwin is a next-generation genomics platform combining leading genomics expertise with data science to transform pathogen detection and immune response assessment. Their platform simultaneously profiles both pathogens and host immune determinants, achieving 98% diagnostic accuracy across 100+ pathogen types, and enables real-time surveillance integration for public health decision-making and precision treatment strategies.
Summary
GenoTwin is an Agtech company based in New York, United States, founded in 2020. It has raised $200K in total across 1 round, most recently a $200K Seed round in Dec 2020. Investors include SOSV and IndieBio.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2020
Investors
Similar Companies
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...